Watchlist Price Alert

Idera Pharmaceuticals Inc... (IDRA)

NASDAQ: IDRA · Real-Time Price · USD

0.42

-0.13 (-23.94%)

At close: Jan 17, 2023, 9:00 PM

Idera Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-23.36M	98.09M	-112.66M	-56.52M	-59.88M	-65.98M	-38.39M
Depreciation & Amortization	15K	22K	61K	120K	432K	746K	656K
Stock-Based Compensation	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Working Capital	-254K	2.14M	511K	-2.16M	2.15M	-2.66M	-47K
Other Non-Cash Items	2.73M	-125.64M	76.31M	11.32M	574K	244K	742K
Deferred Income Tax	-6.32M	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	254K	388K	-1.12M	-3.27M	1.28M	-985K	1.94M
Operating Cash Flow	-24.5M	-24.6M	-33.77M	-44.5M	-51.92M	-55.26M	-28.2M
Capital Expenditures	n/a	n/a	-8K	-11K	-75K	-206K	-408K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	-12.18M	-44.5M	n/a	n/a	-2.95M
Sales Maturities Of Investments	n/a	4.5M	10.5M	42.1M	n/a	28.27M	34.72M
Other Investing Acitivies	5.48M	n/a	n/a	11K	290K	28.06M	n/a
Investing Cash Flow	5.48M	4.5M	-1.69M	-2.4M	215K	28.06M	31.37M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-1.49M	19.41M	28.67M	15.49M	10.19M	59.16M	50.92M
Financial Cash Flow	-1.49M	19.41M	28.67M	15.49M	10.19M	59.16M	50.92M
Net Cash Flow	-20.5M	-684K	-6.79M	-31.41M	-41.51M	31.96M	54.08M
Free Cash Flow	-24.5M	-24.6M	-33.78M	-44.51M	-51.99M	-55.47M	-28.61M